Skip to main content

Table 4 Time to complete the myTAPS (N = 2000)

From: Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool

  Number of participants
n (%)
Time in minutes
median/mean (SDa)
Wilcoxon
testb
All participants 2000 (100) 4.00/4.48 (2.57)  
Gender
 Women 1124 (56.2) 3.00/3.95 (2.00) 10.99***
 Men or other 876 (43.8) 4.00/5.17 (2.94)
Age
 Younger participants (18–25) 225 (11.3) 3.00/3.00 (1.08) 11.20***
 Participants > 25 1775 (88.7) 4.00/4.67 (2.67)
 Older participants (> 65) 160 (8.0) 5.00/6.14 (3.30) − 9.03***
 Participants < 65 1840 (92.0) 4.00/4.34 (2.44)
Race
 Black/African American 1112 (55.6) 4.00/4.73 (2.58) − 6.48***
 Non-Black/African American 888 (44.4) 3.00/4.17 (2.52)
Ethnicity
 Hispanic 233 (11.7) 4.00/5.03 (3.00) − 3.52***
 Non-Hispanic 1767 (88.3) 4.00/4.41 (2.50)
Education level
 Less than high school (HS) 383 (19.2) 5.00/6.00 (3.26) − 12.28***
 HS or higher 1617 (80.8) 4.00/4.12 (2.23)
Alcohol use
 Screened positivec 858 (42.9) 4.00/4.61 (2.68) − 1.87
 Screened negative 1142 (57.1) 4.00/4.38 (2.48)
Illegal drug use
 Screened positivec 492 (24.6) 4.00/4.93 (2.52) − 5.91***
 Screened negative 1508 (75.4) 4.00/4.34 (2.57)
Prescription drug use
 Screened positivec 245 (12.3) 5.00/5.31 (2.72) − 6.33***
 Screened negative 1755 (87.7) 4.00/4.37 (2.53)
Order of administration
 myTAPS first 1002 (50.1) 4.00/4.85 (2.84) 6.59***
 Interviewer-administered first 998 (49.9) 4.00/4.11 (2.21)
  1. Electronic self-administered format of the tobacco, alcohol, prescription medication, and other substance use (TAPS)
  2. aStandard deviation
  3. bWilcoxon test assessed the difference between each subgroup versus all other participants (i.e. women versus non-women)
  4. cScreened positive on myTAPS-1
  5. *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001